Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mehdi

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 25, 2019
Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survivalCarlo J Iasella, Spencer A Winters, Abigail Kois, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
Journal of Medicinal Chemistry|July 3, 1998
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Plos Pathogens|May 2, 2013
Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityMarie-Line Goulet, David Olagnier, Zhengyun Xu, et al.
The European Respiratory Journal|January 30, 2025
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung diseaseGillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 25, 2019
Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survivalCarlo J Iasella, Spencer A Winters, Abigail Kois, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.
Journal of Medicinal Chemistry|July 3, 1998
Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Plos Pathogens|May 2, 2013
Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityMarie-Line Goulet, David Olagnier, Zhengyun Xu, et al.
The European Respiratory Journal|January 30, 2025
Accelerated epigenetic ageing worsens survival and mediates environmental stressors in fibrotic interstitial lung diseaseGillian C Goobie, Daniel-Costin Marinescu, Ayodeji Adegunsoye, et al.
American Journal of Respiratory and Critical Care Medicine|June 20, 2025
Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung DiseaseGillian C Goobie, Najmeh Assadinia, Chen Xi Yang, et al.
Pageof 18